Skip to Content Facebook Feature Image

Thermo Fisher Scientific Launches Gibco™ VaxEvo™ CD 293 Medium to Advance Adenovirus Vaccine Production

Business

Thermo Fisher Scientific Launches Gibco™ VaxEvo™ CD 293 Medium to Advance Adenovirus Vaccine Production
Business

Business

Thermo Fisher Scientific Launches Gibco™ VaxEvo™ CD 293 Medium to Advance Adenovirus Vaccine Production

2026-11-18 21:32 Last Updated At:21:40

WALTHAM, Mass.--(BUSINESS WIRE)--Nov 18, 2026--

Thermo Fisher Scientific, the world leader in serving science, today announced the Gibco™ VaxEvo™ CD 293 Medium, a chemically defined and animal origin-free medium designed to support suspension HEK293 cell growth and high-titer adenovirus production. Available in liquid and AGT™ formats, the medium is designed to support vaccine developers from early process development through scale-up and manufacturing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261118289303/en/

As suspension-based HEK293 workflows evolve to support scalable adenoviral vectors and adenovirus vaccine production, developers need media that can help deliver strong productivity while reducing process complexity and supporting manufacturing readiness. VaxEvo CD 293 Medium is designed to address these evolving needs.

“Manufacturing readiness begins well before a process reaches the plant. The choices vaccine developers make during process development can shape how they evaluate performance, complexity and the path to scale,” said Alex Cherkassky, vice president and general manager of Thermo Fisher Scientific’s cell culture business. “We developed Gibco VaxEvo CD 293 Medium as a purpose-built starting point to help customers advance suspension-based adenovirus HEK293 processes with greater confidence.”

In laboratory benchmarking studies using HEK293 cells, VaxEvo CD 293 Medium supported average adenovirus type 5 (Ad5) titers comparable to select supplier media, with results reaching up to 5.7-fold higher titers in some comparisons.

The product will be available in liquid and multiple AGT™ package sizes.

To learn more about the Gibco™ VaxEvo™ CD 293 Medium, please visit thermofisher.com/VaxEvo-CD293-Media.

Frequently Asked Questions

What is Gibco™ VaxEvo™ CD 293 Medium?

A chemically defined, animal origin-free cell culture medium designed to support suspension HEK293 cell growth for adenoviral vectors, adenovirus vaccine, and oncolytic virus production.

Who is it designed for?

Vaccine process development scientists and upstream manufacturing teams at human and animal health vaccine manufacturers using suspension HEK293 cells, particularly for adenovirus-based applications.

What problem does it address?

VaxEvo CD 293 Medium addresses the need for a chemically defined suspension medium that supports robust HEK293 cell growth and adenovirus productivity while reducing process complexity. In benchmarking studies, VaxEvo CD 293 Medium demonstrated comparable or higher titers without a dedicated feed versus select benchmark media used with their recommended feeds.

Why does it matter?

VaxEvo CD 293 Medium combines adenovirus productivity, robust cell growth and process simplicity in a chemically defined, animal origin-free platform available in scalable liquid and AGT™ formats, helping support progression from vaccine process development toward manufacturing.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.

© 2026 Thermo Fisher Scientific Inc. All rights reserved.

All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries unless otherwise specified

Gibco™ VaxEvo™ CD 293 Medium Collection

Gibco™ VaxEvo™ CD 293 Medium Collection

PARIS (AP) — Russia is responding forcefully to confirmation from France that it periodically sends military personnel into Ukraine to provide training and maintenance help with some of the weaponry it has supplied for the war.

Russian Foreign Minister Sergey Lavrov said: “This is no longer ‘support for Ukraine,' but direct participation in the war.”

France says the soldiers and weapons specialists are noncombatants.

“Since we are not at war with Russia, these, in fact, are not combat units,” French Deputy Defense Minister Alice Rufo said.

Here's a closer look:

Speaking on Wednesday to French broadcaster RMC, Rufo said French personnel are “a very long way from the front line. They come to carry out occasional missions.”

She didn't specify their numbers, but said that they are “a few soldiers, specialists, including armaments engineers, who work — or can come to work — on an occasional basis to maintain complex equipment, such as Mirage aircraft or Caesar howitzers, and provide targeted training on certain equipment.”

France first delivered Mirage 2000-5 fighters last year to Ukraine and trained pilots and mechanics for them. The French Defense Ministry says the aircraft have helped fend off missile and drone attacks.

It also says that with donations from allies and purchases, Ukraine's force of high-precision French-made Caesar howitzers has grown to become the largest in the world.

France has also supplied precision bombs, cruise missiles, air defense systems, light tanks and other equipment.

Rufo told French lawmakers on Tuesday that France is “accelerating” its support in light of Russia's air campaign against Ukrainian targets. She spoke of a “complete absence of any intention to engage in combat” and described as “absurd” Lavrov's accusation that France is directly participating in the war.

Only a “very limited" number of French personnel are engaged in “the extremely limited” missions, Rufo said.

Her comments came after French media, including broadcaster RFI and Le Monde newspaper, reported that small contingents of French military officers stay in Ukraine for short rotations as part of the so-called Operation Volia, since at least this summer.

French military personnel have been operating in Ukraine for more than six months and France isn't alone in providing such support, Lavrov said Tuesday at a news conference in Manila, Philippines, where he was attending a summit of Southeast Asian nations.

“We have conveyed our concern through the available channels, warning the relevant countries that this is no longer ‘support for Ukraine,’ but direct participation in the war,” he said, without naming the countries.

“This is just like the assistance with target designation, the provision of satellite data and much else,” he said.

Russian Foreign Ministry spokesperson Maria Zakharova said that Moscow will regard any foreign troops in Ukraine as legitimate targets and it will be up to the Russian military to determine a response.

The United Kingdom has soldiers in Ukraine, but officials haven't disclosed how many or what their role is. The U.K. Defense Ministry confirmed two deaths of British soldiers in Ukraine in the past year, in both cases in accidents.

Since Russia launched a full-scale invasion of Ukraine on Feb. 24, 2022, dozens of countries have trained more than 100,000 Ukrainian soldiers, at locations outside the country — in France, the U.K., the United States, Poland, Germany and elsewhere — including on Patriot missile batteries, F-16 combat jets and other equipment. They have also trained recruits, officers, medics and other specialists for combat.

Jill Lawless in London, Sylvie Corbet and Catherine Gaschka in Paris, and Lorne Cook in Brussels, contributed to this report.

Russian Foreign Minister Sergey Lavrov attends the joint meeting of the Collective Security Treaty Organization (CSTO) Council of Foreign Ministers, Council of Ministers of Defence and Committee of Secretaries of Security Councils in Moscow, Tuesday, Nov. 10, 2026. (AP Photo/Pavel Bednyakov)

Russian Foreign Minister Sergey Lavrov attends the joint meeting of the Collective Security Treaty Organization (CSTO) Council of Foreign Ministers, Council of Ministers of Defence and Committee of Secretaries of Security Councils in Moscow, Tuesday, Nov. 10, 2026. (AP Photo/Pavel Bednyakov)

Recommended Articles